VIDEO: An Introduction to a New and Innovative Way of Making Uniform, Size-controlled Embryoid Bodies
Hysterectomies a Stem Cell Source
Discarded fallopian tubes from hysterectomies could be a good source of donor stem cells, say Brazilian researchers.
Tulane Scientist to Study Limb Regeneration
With the help of a $6.25 million U.S. Department of Defense grant, Tulane University professor Ken Muneoka will lead a team to identify the genes that trigger regeneration in the axolotl, a Mexican salamander.
Researchers Suggests Gene Inhibition May Help Normalize Type 2 Diabetes
In research that could lead to new approaches for the treatment of type 2 diabetes, a Yale School of Medicine team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease in a rat model.
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Pluristem Therapeutics Inc. announced recently the German competent authority in the European Union, has approved the Company’s Clinical Trial Application and granted approval to begin clinical trials with its placental-derived adherent stromal cell product.
Living Cell Technologies’ Accepts Proposed Revised Conditions for Diabetes Clinical Trial in New Zealand
Living Cell Technologies recently announced the Company has accepted a preliminary decision from the New Zealand Minister of Health to issue a new conditional authorization for its New Zealand Phase I/IIa clinical trial of DIABECELL(R) for insulin dependent diabetes.
Study Identifies Benefit of Donor Stem Cell Transplantation for Adults with Acute Myeloid Leukemia
A stem cell transplant from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia.
FDA Removes Clinical Hold from Aastrom Phase II IMPACT-DCM Clinical Trial
Aastrom Biosciences, Inc. recently reported that the U.S. Food and Drug Administration has removed the clinical hold from the Company’s U.S. Phase II IMPACT-DCM clinical trial and that patient enrollment would resume at all five initiated clinical sites.
University of Pittsburgh Cancer Institute Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
The phase III study is assessing the safety and efficacy of StemEx(R), an investigational product derived from stem cells, as an alternative treatment to bone marrow transplants for hematological malignancies, including leukemia and lymphoma.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
CEO Pay of 2008: Who Makes What in Big Biotech?
Since biotech companies each have their own approach to reporting CEO pay, ranking were based on total compensation reported in these companies’ SEC filings.
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.